Speakers

Commander Fine is the Senior Advisor in the Office of Generic Drug ‘s, Office of Safety and Clinical Evaluation, Division of Clinical Review. As part of the division management team, Commander Fine, provides clinical, regulatory, and process oversight for generic drug activities in the division. Prior to his role as Senior Advisor, Commander Fine served as a team leader in the division for 7 years where he led a team of physicians in their clinical work to support the Generic Drug Program. He earned his PharmD from the University of Illinois College of Pharmacy and completed a pharmacy practice residency at Northwestern Memorial Hospital. Andrew is board certified in pharmacotherapy and earned a certificate in pharmacoepidemiology from the University of Pennsylvania. Prior to joining the Office of Generic Drugs, CDR Fine spent 4.5 years as a safety reviewer in CDER’s Office of Surveillance and Epidemiology, Division of Pharmacovigilance where he led postmarketing safety efforts for Multiple Sclerosis drug products